Human IL-23 R PharmaGenie ELISA Kit (SBRS0762)

Quantitative measurement of interleukin-23 receptor (IL-23R) in human research samples is supported by this solid-phase immunoassay from Assay Genie. The kit targets the IL-23R subunit implicated in Th17 cell signaling, JAK/STAT pathway activation, and chronic inflammatory disease research, including psoriasis, Crohn's disease, and rheumatoid arthritis studies.

Configured for 96 assays in a microplate format, the product accommodates moderate-throughput screening of patient cohorts or treatment time-course experiments. The assay is reactive with human IL-23R and accepts serum or plasma specimens alongside cell culture supernatant samples, supporting translational workflows that bridge cell-based models and clinical biobank material.

Researchers examining receptor expression on activated T cells, dendritic cells, or macrophages following cytokine stimulation will find this reagent fits standard immunology laboratory practice. Components are supplied in individual vials for reconstitution prior to first use, and the workflow follows conventional incubation and wash steps characteristic of plate-based ligand-binding assays used in cytokine receptor profiling studies.